EMFO LLC’s Altimmune ALT Stock Holding History

EMFO LLC’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	-$43.6K	–	310
2022 Q4	–	Hold	0	–	–	–	162
2022 Q3	–	Hold	0	–	–	–	181
2022 Q2	–	Hold	0	–	–	–	188
2022 Q1	–	Sell	-5,000	Closed	-$46K	–	331
2021 Q4	$46K	Buy	+5,000	New	+$53.1K	0.04%	204

Other funds holding ALT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

EMFO LLC's ALT Position: Q4 2021 in Review

EMFO LLC sold out of Altimmune (ALT) in Q4 2021, closing a stake of 5,000 shares — an estimated $53.1K sold.

EMFO LLC first reported a position in ALT in Q2 2021 and held it in 2 quarters. The position peaked at $57K in Q3 2021. 102 funds tracked by Wall St. Rank hold ALT as of Q4 2021.

EMFO LLC reported no remaining Altimmune position as of Q4 2021 after selling out during the quarter.
EMFO LLC sold 5,000 Altimmune shares in Q4 2021, an estimated $53.1K.
EMFO LLC first reported a position in Altimmune in Q2 2021 and held it in 2 quarters.
EMFO LLC's Altimmune position peaked at $57K in Q3 2021.
102 funds tracked by Wall St. Rank held Altimmune as of Q4 2021.

Based on EMFO LLC's 13F filing for Q4 2021, filed 27 Jan 2022.